Cadrenal Therapeutics Statistics
NASDAQ: CVKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.90-0.0723 (-7.39%)
Market open · Delayed 15 min · as of Oct 8, 10:21 AM ET
Cadrenal Therapeutics by the numbers
Cadrenal Therapeutics has a market capitalization of $3.2 million based on 3.57M shares outstanding. With trailing EPS of $-4.91, Cadrenal Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.9% below its 50-day average and 80.0% below its 200-day average.
Average daily trading volume is 454.72K shares, or about $409,246 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CVKD valuation vs. peer median
| Metric | CVKD | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.21M | $3.51M | -8% |
| Avg. volume | 454.72K | 252.88K | +80% |
Peer median across 8 companies: SXTP, JUNS, HCWB, CMND, EOCN, ERNA, KAPA, MBIO.
Valuation
- Market cap
- $3.21M
- EPS (TTM)
- $-4.91
- Shares outstanding
- 3.57M
Price and trading
- Previous close
- 0.9723
- Open
- 0.9939
- Day range
- 0.88 – 0.9939
- 52-week range
- 0.85 – 14.50
- Beta
- —
- Volume
- 190.36K
- Average volume
- 454.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 3.21M
- Forward Pe
- -0.26
- Eps
- -4.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.50
- Week52 Low
- 0.85
- Avg Volume
- 454.72K
- Shares Outstanding
- 3.57M
- Ma50
- 1.45
- Ma200
- 4.50
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -93.79%
- Pct From52w Low
- 5.88%